Fin Cascade
Get Android appGet iOS app

Prices as of 9 Oct 2026 close · Not investment advice

Insecticides (India) Limited

NSE: INSECTICIDPesticides & Agrochemicals

Share price

₹581.30

+1.71% close of 9 Oct 2026

Market cap ₹1,686 CrP/E 13.5

Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 8 Oct 2026, the close above is 9 Oct 2026.

Business score

How strong the business is, in one number. The parts behind it are in Pro.

62

out of 100 · worked out 9 Oct 2026

How the business score works

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹1,686 Cr

P/E ratio

13.5

P/B ratio

1.4

ROCE

15.8%

ROE

12.1%

Dividend yield

0.3%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 9 Oct 2026 close52-week high ₹770.0052-week low ₹528.40

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Our sales figures for this company step up at Jun 2018 and we hold nothing that says why, so we cannot honestly quote a growth rate across it.

Whether it grew faster than its sector

Our sales figures for this company step up at Jun 2018 and we hold nothing that says why, so there is no honest growth rate of its own to set against its sector.

Room to re-rate, or risk of de-rating

At 13.5× earnings against a market that pays 24.1× across 2199 companies we can price. Its own industry sits at 21.4×, across 5 companies. It is against its own five-year median of 15.5×, the 28th percentile of its own range.

Whether growth justifies the valuation

Priced at 0.4 times its growth rate, on earnings growth of 30%.

Profit growthPrice per ₹1 profitPer 1% growth
Insecticides (India) Limited — this one30%/yr13.5×₹0.45
UPL Limited-21%/yr20.9×—
PI Industries Limited-1%/yr29.4×—
Sumitomo Chemical India Limited2%/yr36.4×₹18.2
Bayer Cropscience Limited1%/yr21.4×₹21.4
Sharda Cropchem Limited26%/yr10.4×₹0.40

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Pesticides & Agrochemicals), it ranks 11 of 23 on returns, 12 of 23 on growth, 14 of 23 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

A narrow advantage: it earns 15.8% on capital, ahead of 52% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

Yes — Over the last five years it made ₹504 crore of cash from the business, spent ₹324 crore on plant and equipment, and returned ₹176 crore to lenders and shareholders. And the profit is real: of every 100 rupees it reported over 12 years, about 94 arrived as cash. Its cash comes back faster than it used to: it went from being waiting 111 days for its cash to waiting 105 days for its cash.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

9 of 10 checks clear · 90%

How the profit check works

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Announced 11 Aug 2026 · Consolidated · Unaudited

Revenue

₹612 Cr

Revenue vs last year

-11.5%

Revenue vs last quarter

+43.6%

Net profit

₹44 Cr

Profit vs last year

-24.4%

Profit vs last quarter

+265.6%

Net margin

7.2%

EPS

₹15.08

Earnings call transcript · 11 Aug 2026

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹1,686 Cr
Prev close
₹581.30
52w High
₹775
52w Low
₹519
Enterprise value
₹1,751 Cr
Beta
0.8
Price CAGR 1y
-19.0%
Price CAGR 3y
5.0%
Price CAGR 5y
4.0%
Price CAGR 10y
6.0%

Ratios

Return on assets
7.0%
PEG ratio
0.4
P/E ratio
13.5
P/B ratio
1.4
EV / EBITDA
8.4
Industry P/E
20.1
ROCE
15.8%
ROCE 5y average
14.4%
ROE
12.1%
Debt / Equity
0.1
Interest coverage
12.0
Dividend yield
0.3%
ROE 3y average
12.0%
ROE last year
12.0%

Annual P&L

Annual revenue
₹2,140 Cr
Annual profit
₹139 Cr
Operating margin
11.0%
Net profit margin
6.5%
EBITDA margin
10.6%
Sales growth 3y
5.9%
Sales growth 5y
8.5%
Profit growth 3y
30.0%
Profit growth 5y
6.0%
EPS
₹47.9
Sales growth TTM
1.0%
Profit growth TTM
-17.0%
Dividend payout
4.0%

Quarter P&L

Sales latest quarter
₹612 Cr
Profit latest quarter
₹44 Cr
YoY quarterly sales growth
-11.5%
YoY quarterly profit growth
-24.1%
OPM latest quarter
11.1%

Balance Sheet

Book Value
₹421
Face Value
₹10.0
Total debt
₹157 Cr
Total cash
₹87 Cr
Borrowings
₹157 Cr
Reserves / Equity
41.1

Cash Flow

Operating cash flow
₹100 Cr
Free cash flow
₹8 Cr
FCF yield
-0.5%
Net cash flow
₹31 Cr

Shareholding

Promoter holding
72.3%
FII holding
4.4%
DII holding
9.3%
Public holding
14.0%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
UPL495.0021.141,7731.21-73.092.610,181.010.510.1
P I Industries2,210.0031.033,5300.68244.2-39.01,702.3-10.415.0
Sumitomo Chemi.421.9536.921,0610.31216.59.31,054.10.623.5
Bayer Crop Sci.3,491.5021.415,6924.30321.615.41,835.0-4.229.1
Sharda Cropchem742.0510.76,6952.0288.0-38.31,073.89.030.3
Dhanuka Agritech891.8014.83,9760.2236.3-34.6461.9-12.623.8
Rallis India200.0317.03,8901.50125.030.01,022.06.814.1
Insecticid.India586.6013.61,7070.3443.9-24.5611.5-11.515.8
Median316.2021.11,6520.1724.616.8383.7-2.315.4

Competes with: Bayer Cropscience Limited, Dhanuka Agritech Limited, NACL Industries Limited, PI Industries Limited, Rallis India Limited, Sharda Cropchem Limited, Sumitomo Chemical India Limited, UPL Limited

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Consolidated · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales640696358273657627358359691638385426612
Expenses594614332264585538327330607548358401544
Material Cost326373363218247358
Change in Inventories-11172-2.8927-0.84-47
Purchases of Stock-in-Trade1245581552107
Employee Cost294248363847
Other Expenses747682616578
Operating Profit4682269729031288589272568
OPM %7.13127.273.2711148.647.9312147.115.8911
Other Income4015320343156
Exceptional items (within Other Income)000000
Interest3332221244545
Depreciation77787787799910
Profit before tax4072174668222227779141659
Tax %262628-106252522372525272725
Net Profit2953128496117145859101244
EPS in Rs9.85184.162.6217215.974.7720203.614.0215
Diluted EPS in Rs4.7720203.604.0215

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Consolidated · to 31 Mar 2026
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales8939069941,0731,1941,3631,4201,5041,8011,9662,0002,1402,060
Expenses7828148829251,0061,2071,2681,3331,6791,8041,7791,9131,851
Material Cost1,3481,200
Change in Inventories-6495
Purchases of Stock-in-Trade75170
Employee Cost139164
Other Expenses281284
Operating Profit11192112148188156153171122162221227210
OPM %121011141611111178111110
Other Income007313-2311081214
Exceptional items (within Other Income)00
Interest33262016152477131171718
Depreciation15161617202425262629293638
Profit before tax64508211815311112014184132193187168
Tax %142127292022212425232625
Net Profit55406084123879410763102142139125
EPS in Rs19131927402830362134494843
Diluted EPS in Rs4848
Dividend Payout %010753104614944

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
9%
5 years
9%
3 years
6%
TTM
1%

Compounded profit growth

10 years
13%
5 years
6%
3 years
30%
TTM
-17%

Stock price CAGR

10 years
6%
5 years
4%
3 years
5%
1 year
-19%

Return on equity

10 years
13%
5 years
11%
3 years
12%
Last year
12%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital132121212121212030302929
Reserves2783884445276417118008508899821,0551,191
Borrowings3222062371143051911005416387105157
Other Liabilities308321277338388372505473615620709623
Minority Interest00
Total Liabilities9209369781,0001,3561,2941,4261,3961,6961,7191,8982,000
Fixed Assets210198185232240239239253263286282370
CWIP3851581719395991123142161130
Investments3311171212141617232929
Other Assets6706847257351,0841,0041,1151,0371,2941,2681,4261,472
Total Assets9209369781,0001,3561,2941,4261,3961,6961,7191,8982,000

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-6864182-133242155135-1118793100
Cash from Investing Activity-34-19-14-26-49-24-1139-86-46-38-86
Cash from Financing Activity36-649-143172-159-104-11580-98-6118
Net Cash Flow-44-013-1159-6130-1742-531
Free Cash Flow-4067-10154-17121310868-97143597.44

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days688478807586657060557083
Inventory Days220190232214355202248228247221268215
Days Payable11811410812814196136117128115154121
Cash Conversion Cycle170159201166289192177181178161185177
Working Capital Days40758093116981081119297106105
ROCE %1216202114151610131716

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Consolidated · to 30 Sep 2026
Line itemDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters727272727272727272727272
FIIs4.414.314.365.435.134.504.654.514.464.504.404.44
DIIs9.129.149.089.069.249.599.729.509.409.279.269.26
Public141414131314131414141414
No. of Shareholders18,23219,25219,47422,48422,84922,68821,43622,33622,35922,27421,38019,691

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year -21.7% (₹742.50 → ₹581.30)Brick size ₹18.23 (fixed)Bricks 41
₹700₹581Nov '25Feb '26Apr '26Jun '26Aug '26Oct '26
Price moved up one brickPrice moved down one brickLast close ₹581.30 on 9 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

exports as % of revenue

2.00pct

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash

65.55inr_cr

2026-03-31

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-09-30

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-09-30

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-09-30

FY revenue / permanent employees + workers, same basis (calc)

1,22,59,240inr

2026-03-31

volume growth %

-13.00pct

2026-06-30

News

News and filings about Insecticides (India) Limited. Open one to see why it matters.

No recent news for this company.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Competes with

Uses as raw material

  • agrochemical technical raw materials / active ingredients
  • packing material
  • process chemicals, stores & spares
  • traded agrochemical goods

Buys drug ingredients from

  • Momentive Performance Materials Inc.
  • Nissan Chemical Corporation
  • OAT Agrio Co., Ltd.

Sells to

  • Crystal Crop Protection Limited · finished agrochemical / crop-protection & nutrition products (Tractor, Hercules, Lethal br…
  • HPM Chemicals & Fertilizers Limited · finished agrochemical / crop-protection & nutrition products (Tractor, Hercules, Lethal br…

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Chemicals
Industry
Pesticides & Agrochemicals
Classification
Chemicals › Pesticides & Agrochemicals
ISIN
INE070I01018

Plants

  • IIL Chopanki formulation & technical unit
  • IIL Dahej technical synthesis unit
  • IIL Samba unit
  • IIL Sotanala formulation & technical unit (upcoming)
  • IIL Udhampur unit

News impact

Big market events that reach Insecticides (India) Limited, and how the effect spreads.

Who it hits first

  • Paraquat sellers (INSECTICID and few non-listed makers) — direct revenue impact in AP
  • Substitute herbicide makers (UPL, RALLIS, BAYERCROP, DHANUKA) — substitution opportunity

Who may gain

  • Glyphosate, glufosinate, atrazine, 2,4-D substitute portfolio holders

Along the supply chain

Downstream

AP farmers + agri-input dealers shift purchase patterns; some farmer education needed.

Upstream

Paraquat manufacturers (mostly MNC + INSECTICID) face inventory at risk of write-down if other states follow.

Where demand moves

Business

Paraquat demand falls 100% in AP for 60 days; substitute herbicide demand rises proportionally; channel inventory rebalance.

Capital

Marginal flow to UPL/RALLIS/BAYER from INSECTICID and other paraquat-heavy mid-caps.

How it spreads across sectors

Chemicals (Agrochemicals)

substitution within agrochem portfolio; net neutral at sector level

When it plays out

Immediate

INSECTICID under pressure; UPL/RALLIS marginal positive

Medium term

1-6 months: other state risk; review at 60 days could extend ban

Short term

1-4 weeks: AP monsoon season demand shift visible

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

6 Feb 2026interim₹2
23 Aug 2024interim₹2
10 Nov 2023interim₹3
24 Feb 2023interim₹3
30 Sep 2022bonus₹0
15 Sep 2022unspecified₹3
19 Nov 2020interim₹2
19 Mar 2020interim₹4

Splits, bonuses & buybacks

  • daily-prices repair: 9 rows from NSE's archive (replace 1, delete 1, insert 7), 2016-10-30..2026-02-01 (docs/flat_day_repair.md)1× · 30 Oct 2016

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.